ArticleTherapeutic advances in neurological disorders2025

Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates.

Jihad Inshasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.